132 related articles for article (PubMed ID: 21285680)
1. F-18 FDG PET/CT imaging of bulky myxofibrosarcoma in chest wall.
Ito K; Masuda-Miyata Y; Wada S; Morooka M; Yamasawa K; Hashimoto M; Kubota K
Clin Nucl Med; 2011 Mar; 36(3):212-3. PubMed ID: 21285680
[TBL] [Abstract][Full Text] [Related]
2. [Dedifferentiated Chondrosarcoma of the Chest Wall].
Saitoh G; Yoneshima Y; Nakamura T; Kitagawa D; Kinjo N; Ohgaki K; Maehara S; Teramoto S; Adachi E; Ikeda Y; Mine M
Kyobu Geka; 2016 Aug; 69(9):764-7. PubMed ID: 27476566
[TBL] [Abstract][Full Text] [Related]
3. A first described chest wall metastasis from colon cancer demonstrated with (18)F-FDG PET/CT.
Jiang L; Gao Y; Sheng S; Xu M; Lu L; Lu H
Hell J Nucl Med; 2011; 14(3):316-7. PubMed ID: 22087459
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET/CT imaging of multiple myxofibrosarcoma in left upper abdomen and chest wall.
Yi C; Wang X; Shi X; Zhang X; Chen Z
Nuklearmedizin; 2012; 51(6):N53-4. PubMed ID: 23250511
[No Abstract] [Full Text] [Related]
5. [The role of 18F-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) in liposarcoma of the chest wall].
Yamamoto H; Sugimoto S; Miyoshi K; Yamamoto H; Soh J; Yamane M; Toyooka S; Oto T; Miyoshi S
Kyobu Geka; 2014 Jan; 67(1):4-8. PubMed ID: 24743405
[TBL] [Abstract][Full Text] [Related]
6. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
7. Acute Presentation of a High-Grade Myxofibrosarcoma Originating in the Thoracic Wall: A Case Report.
D'Angelo LA; Arora Y; Carrillo RG
Chest; 2022 Jan; 161(1):e1-e4. PubMed ID: 35000710
[TBL] [Abstract][Full Text] [Related]
8. Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology patients: how often are they malignant?
Kumar R; Hawkins RA; Yeh BM; Wang ZJ
Nucl Med Commun; 2011 Sep; 32(9):802-7. PubMed ID: 21685821
[TBL] [Abstract][Full Text] [Related]
9. Appearance of recurrent cardiac myxofibrosarcoma on FDG PET/CT.
Erdoğan EB; Asa S; Aksoy SY; Ozhan M; Halac M
Clin Nucl Med; 2014 Jun; 39(6):559-60. PubMed ID: 24662649
[TBL] [Abstract][Full Text] [Related]
10. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET/CT Images in a Patient With Primary Chest Wall Tuberculosis Mimicking Malignant Tumor.
Wang SY; Luo DL; Chen G; Wang SX
Clin Nucl Med; 2016 Apr; 41(4):323-5. PubMed ID: 26505862
[TBL] [Abstract][Full Text] [Related]
12. Incidental detection of bilateral elastofibroma dorsi with F-18 FDG PET/CT.
Wasyliw CW; Caride VJ
Clin Nucl Med; 2005 Oct; 30(10):700-1. PubMed ID: 16166850
[TBL] [Abstract][Full Text] [Related]
13. Adrenal masses: the value of additional fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) in differentiating between benign and malignant lesions.
Okada M; Shimono T; Komeya Y; Ando R; Kagawa Y; Katsube T; Kuwabara M; Yagyu Y; Kumano S; Imaoka I; Tsuchiya N; Ashikaga R; Hosono M; Murakami T
Ann Nucl Med; 2009 Jun; 23(4):349-54. PubMed ID: 19340526
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of soft-tissue lesions with (18)F-FDG PET/CT: initial results of a prospective trial.
Leal AL; Etchebehere M; Santos AO; Kalaf G; Pacheco EB; Amstalden EM; Etchebehere EC
Nucl Med Commun; 2014 Mar; 35(3):252-9. PubMed ID: 24300379
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of conventional whole-body ¹⁸F-FDG PET/CT in the incidental findings of parotid masses.
Wang HC; Zuo CT; Hua FC; Huang ZM; Tan HB; Zhao J; Guan YH
Ann Nucl Med; 2010 Oct; 24(8):571-7. PubMed ID: 20640540
[TBL] [Abstract][Full Text] [Related]
16. FDG PET/CT findings in recurrent malignant schwannoma.
Halac M; Cnaral F; Sait S; Ylmaz S; Kerim S; Sergülen D; Uslu I
Clin Nucl Med; 2008 Mar; 33(3):172-4. PubMed ID: 18287838
[TBL] [Abstract][Full Text] [Related]
17. Imaging with 18F-FDG PET/CT of a primitive primary neuroectodermal tumor of the chest wall, in an adult.
Kamaleshwaran KK; Mittal BR; Chakraborty D; Bhattacharya A; Gupta N; Jindal SK
Hell J Nucl Med; 2010; 13(3):287-8. PubMed ID: 21193890
[No Abstract] [Full Text] [Related]
18. Solitary Chest Wall Tuberculosis Mimicking a Malignancy Demonstrated on FDG PET/CT.
Xiao L; Li Y; Li L
Clin Nucl Med; 2022 Sep; 47(9):e609-e610. PubMed ID: 35439192
[TBL] [Abstract][Full Text] [Related]
19. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
20. Value of positron emission tomography in full-thickness chest wall resections for malignancies.
Petermann D; Allenbach G; Schmidt S; Letovanec I; Christodoulou M; Delaloye AB; Ris HB; Prior JO
Interact Cardiovasc Thorac Surg; 2009 Sep; 9(3):406-10. PubMed ID: 19515673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
